-
Mapping the Rare Disease Diagnostic Odyssey of Today: An Adapted Targeted Literature Review (ATLR)
Sep 9, 2025, 16:22 PM -
Flexible Parametric Inference for Cause-Specific Hazard-Competing Risk Models Under Interval Censoring
Sep 9, 2025, 16:22 PM -
Real-World Study on Length of Hospital Stay and Economic Burden of AECOPD Inpatients in a Traditional Chinese Medicine Hospital in China
Sep 9, 2025, 16:22 PM -
Preliminary Real-World Results of a Community Pharmacy-Based Intervention in COPD: Evidence From the Chronic Diseases From A to Z Program
Sep 9, 2025, 16:22 PM -
Concordance Between Patient and Physician Reporting of Symptoms for Metastatic Urothelial Cancer in Europe: A Real-World Survey
Sep 9, 2025, 16:22 PM -
From French Early Access to Regular Reimbursement: How Do Prices Shift Post-HTA?
Sep 9, 2025, 16:22 PM -
Value-Based Assessment of Trifluridine Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
Sep 9, 2025, 16:22 PM -
Costs Associated With the Administration, Postinfusion Monitoring, and Management of Adverse Events (AEs) Related to Novel Drugs for Second-Line (2L+) Treatment of Small-Cell Lung Cancer (SCLC)
Sep 9, 2025, 16:22 PM -
National Competent Authorities’ Experiences With Early Feasibility Study Assessment: Promoting Dialogue, Supporting Sponsors, and Fostering Shared Learning to Harmonize the EU Framework
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Early Scientific Advice Mechanisms: EU JSC vs. National HTA Bodies (HAS, G-BA, NICE)
Sep 9, 2025, 16:22 PM -
Bimekizumab Budget Impact Analysis for the Treatment of Patients With Moderate-to-Severe Hidradenitis Suppurativa (HS) in Greece
Sep 9, 2025, 16:22 PM -
Development of an LLM-Based Computable Phenotype for Pediatric Lymphoma Subtypes Using Structured and Unstructured Electronic Medical Record Data
Sep 9, 2025, 16:22 PM -
Quality-Adjusted Time Without Symptoms or Toxicity Q-TWiST Estimates in Previously Treated HER2-Positive Biliary Tract Carcinoma (BTC) Using the Zanidatamab HERIZON-BTC-01 Study
Sep 9, 2025, 16:22 PM -
Survival Model Uncertainty in Economic Modeling: Evaluating Bootstrap and Cholesky Decomposition Methods
Sep 9, 2025, 16:22 PM -
Potential Operational Efficiencies of a Combination Influenza and COVID-19 Vaccine in US Pharmacies
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of a Digital Health Intervention for Screening and Managing Hypertension at Primary Care Level in Kenya: A Microsimulation Model
Sep 9, 2025, 16:22 PM -
Historical Shifts in Birth Month Distribution in Japan and the Impacts on Health Outcome Studies
Sep 9, 2025, 16:22 PM -
EQ-5D Utility Trends in NMOSD: Impact of Time and Disability
Sep 9, 2025, 16:22 PM -
Assessing the Economic Impact of a Robotic-Assisted Solution vs. a Manual Approach in Total Knee Arthroplasty in the UK
Sep 9, 2025, 16:22 PM -
Surrogate Outcome Validation Within the New EU HTA Guidance Framework: Practical Considerations From an Industry Perspective Based on Experience From HTA Germany
Sep 9, 2025, 16:22 PM
